Kruti Mukesh Patel's Insider Trades & SAST Disclosures
Kruti Mukesh Patel's most recent trade in Zydus Lifesciences Ltd. was a Disposal of 62 Equity Shares done at an average price of Rs. 1005 . Disclosure was reported to the exchange on March 18, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Kruti Mukesh Patel in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | Kruti Mukesh Patel | Directors Immediate Relative | Disposal | 18 Mar 2024 | 62 | 3,896 (0%) | 0.00% | 1005 | 62,310 | 14 Mar 2024 14 Mar 2024 |
Insider Trading | Equity Shares | Buy Back |
| Zydus Lifesciences | Kruti Mukesh Patel | Directors Immediate Relative | Disposal | 27 Jul 2022 | 42 | 3,958 (0%) | 0.00% | 650 | 27,300 | 15 Jul 2022 15 Jul 2022 |
Insider Trading | Equity Shares | Buy Back |
| Zydus Lifesciences | Kruti Mukesh Patel | Directors Immediate Relative | Disposal | 19 Jul 2022 | 42 | 3,958 (0%) | 0.00% | 0 | 0 | 15 Jul 2022 15 Jul 2022 |
Insider Trading | Equity Shares | Buy Back |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.